Free Newsletter
Ireland trumpets Pfizer biotech facility
Pfizer is keeping mum about a biologics facility it's preparing to build in Ireland, but no one else appears to be. Jacobs Engineering, which Pfizer tapped to perform pre-construction services at the site, trumpeted its selection in a press release. And the Irish newspapers, encouraged by the prospect of 100 new high-tech jobs, are all over the story.
"Cork County Council recently granted planning permission for the facility,": writes the Irish Examiner, "and if the plan is approved by Pfizer construction should begin immediately, with the facility expected to be completed by early 2009."
The drug maker says that the proposed biologics facility still hasn't received final, internal approval, and that hiring Jacobs was only a necessary step in its decision-making process. A final determination is expected in October.
- check out the press release from Jacobs
- read this article from the Irish Examiner
Related Articles:
Troubled Pfizer blueprints biotech venture effort. Report
Pfizer to invest $50M in biotech start-ups. Report
Comments
Well it has now been officially confirmed. A welcome addition to Corks thriving industrial base.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





